Article(id=1327671906280518223, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.11.006, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1666195200000, receivedDateStr=2022-10-20, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471249407, onlineDateStr=2026-11-12, pubDate=1668009600000, pubDateStr=2022-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471249407, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471249407, creator=13701087609, updateTime=1794471249407, updator=13701087609, issue=Issue{id=1327671856833868058, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='11', pageStart='1529', pageEnd='1670', issueExtLink='null', onlineDate='null', pubDate='1668009600000', pubDateStr='2022-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471237619, creator='13701087609', updateTime=1794472094917, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327675453114004391, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327675453114004392, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1565, endPage=1570, ext={EN=ArticleExt(id=1327671906431513168, articleId=1327671906280518223, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Cases Analysis and Considerations on Juvenile Toxicology Studies, columnId=null, journalTitle=Chinese Journal of Pharmaceuticals, columnName=null, runingTitle=null, highlight=null, articleAbstract=

In recent years, paediatric pharmaceutical has become a hotspot of drug development and clinical trials in paediatric population have gradually increased. The conduct of juvenile animal studies(JAS) should be considered only when previous nonclinical and clinical data are insufficient to support paediatric clinical trials. A JAS is designed to address safety concerns that cannot be adequately addressed in other nonclinical studies or paediatric clinical trials, including potential long-term safety effects. The ICH S11 Nonclinical safety testing in support of development of pediatric pharmaceuticals was issued in 2020. This article discusses considerations of JAS, combining with ICH S11 guidance and cases analysis, aiming to provide information for pediatric pharmaceutical development in China.

, authors=Xiaolei SHAN, Fanghua HUANG*, Kaidi JIANG, authorsList=Xiaolei SHAN, Fanghua HUANG, Kaidi JIANG, authorCompany=null, correspAuthors=Fanghua HUANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327671907006132817, articleId=1327671906280518223, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=幼龄动物毒理学试验的案例分析及考虑要点, columnId=1327671857534316828, journalTitle=中国医药工业杂志, columnName=本期主题:儿童药创新研发与科学监管, runingTitle=null, highlight=null, articleAbstract=

近年来儿童用药成为药物开发热点,儿童人群临床试验逐渐增多。当支持开展儿童临床试验安全性的非临床和临床数据缺乏时,需要考虑开展幼龄动物试验,旨在阐述在其他非临床试验或儿童临床试验中无法得到充分阐述的安全性问题,包括潜在的长期安全性的影响。该文基于2020年发布的ICH S11支持儿童用药开发的非临床安全性指导原则并结合实际案例,阐述了幼龄动物试验的设计和实施的考虑要点,以期为我国儿童用药开发提供参考。

, authors=单晓蕾, 黄芳华*, 姜凯迪, authorsList=单晓蕾, 黄芳华, 姜凯迪, authorCompany=null, correspAuthors=黄芳华, authorNote=

单晓蕾(1983—),女,硕士,副主任药师,从事新药药理毒理审评工作。

, correspAuthorsNote=
黄芳华(1976—),女,博士,主任药师,从事新药药理毒理审评工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=lm1s/LycJgMkWipDNXGshw==, magXml=jhFicLLBP6ObEXUsNX4t8g==, pdfUrl=null, pdf=hJky4yOs9E/r+KHLGIZWbw==, pdfFileSize=1431853, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=V0fgoCUYYmxhWZha3CORlw==, mapNumber=null, fund=null)}, authors=[Author(id=1327672071976498032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672072106521458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672071976498032, language=EN, stringName=Xiaolei SHAN, firstName=Xiaolei, middleName=null, lastName=SHAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672072186213235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672071976498032, language=CN, stringName=单晓蕾, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

单晓蕾(1983—),女,硕士,副主任药师,从事新药药理毒理审评工作。

"}, bioImg=null, bioContent=

单晓蕾(1983—),女,硕士,副主任药师,从事新药药理毒理审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672071829697388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, xref=null, ext=[AuthorCompanyExt(id=1327672071854863213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672071867446126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672072249127797, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=huangfh@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672072316236663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072249127797, language=EN, stringName=Fanghua HUANG, firstName=Fanghua, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672072383345528, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072249127797, language=CN, stringName=黄芳华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672071829697388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, xref=null, ext=[AuthorCompanyExt(id=1327672071854863213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672071867446126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672072463037306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672072559506300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072463037306, language=EN, stringName=Kaidi JIANG, firstName=Kaidi, middleName=null, lastName=JIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672072635003773, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072463037306, language=CN, stringName=姜凯迪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672071829697388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, xref=null, ext=[AuthorCompanyExt(id=1327672071854863213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672071867446126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1327672072785998718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, language=EN, orderNo=1, keyword=ICH S11), Keyword(id=1327672072865690495, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, language=EN, orderNo=2, keyword=juvenile animal study), Keyword(id=1327672072936993664, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, language=EN, orderNo=3, keyword=paediatric drug development), Keyword(id=1327672073008296833, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, language=CN, orderNo=1, keyword=ICH S11), Keyword(id=1327672073083794306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, language=CN, orderNo=2, keyword=幼龄动物试验), Keyword(id=1327672073146708867, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, language=CN, orderNo=3, keyword=儿童用药开发)], refs=[Reference(id=1327672073339646852, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.S11, Nonclinical safety testing in support of development of paediatric medicines [S/OL].[2022-08-04].https://database.ich.org/sites/default/files/S11_Step4_FinalGuideline_2020_0310.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672073431921541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Guidance for industry: nonclinical safety evaluation of pediatric drug products [EB/OL].[2022-08-04].https://www.fda.gov/media/119658/download., articleTitle=null, refAbstract=null), Reference(id=1327672073515807622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Guideline on the need for nonclinical testing in juvenile animals on human pharmaceuticals for pediatric indications [EB/OL].[2022-08-04].https://www.ema.europa.eu/documents/scientific-guideline/guideline-need-non-clinical-testing-juvenile-animals-pharmaceuticals-paediatric-indications_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672073599693703, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=JP MHLW.Guideline on nonclinical safety studies in juvenile animals for pediatric drug development [EB/OL].[2022-08-04].https://www.pref.kagawa.lg.jp/documents/7476/161_241015.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672073666802568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.M3, Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals [S/OL].[2022-08-04].https://database.ich.org/sites/default/files/M3_R2__Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672073746494345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Label: vimpat [EB/OB].(2008-10-08)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022253lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672075466158986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.NDA 022253 approval letter [EB/OB].(2008-10-28)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022253s000,%20022254s000ltr.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672075575210891, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Label: vimpat [EB/OB].(2022-05-19)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022254Orig1s044,022253Orig1s054,022255Orig1s036lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672075663291276, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.NDA 022253 pharmacology review [EB/OB].(2007-09-28)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022253s000_022254s000TOC.cfm., articleTitle=null, refAbstract=null), Reference(id=1327672075793314701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Label: spinraza [EB/OB].(2016)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209531lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672075931726734, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.NDA 209531 pharmacology review [EB/OB].(2016-9-23)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/209531Orig1s000TOC.cfm., articleTitle=null, refAbstract=null), Reference(id=1327672076133053327, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.NDA 209531 approval letter [EB/OB].(2016-12-23)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/209531Orig1s000ltr.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672076225328016, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=BAILEY G P, MARIËN D.The value of juvenile animal studies “What have we learned from preclinical juvenile toxicity studies? Ⅱ” [J].Birth Defects Res B Dev Reprod Toxicol, 2011, 92(4): 273-291., articleTitle=null, refAbstract=null), Reference(id=1327672076296631185, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=VAN DER LAAN J W, VAN MALDEREN K, DE JAGER N, et al.Evaluation of juvenile animal studies for pediatric CNS-targeted compounds: a regulatory perspective [J].Int J Toxicol, 2019, 38(6): 456-475., articleTitle=null, refAbstract=null), Reference(id=1327672076401488786, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=POSOBIEC L M, LAFFAN S B.Dose range finding approach for rodent preweaning juvenile animal studies[J].Birth Defects Res, 2021, 113(5): 409-426., articleTitle=null, refAbstract=null), Reference(id=1327672076556678035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=FISHER J E Jr, RAVINDRAN A, ELAYAN I.CDER experience with juvenile animal studies for CNS drugs [J].Int J Toxicol, 2019, 38(2): 88-95., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327672071829697388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, xref=null, ext=[AuthorCompanyExt(id=1327672071854863213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672071867446126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.11.006, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.11.006, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.11.006, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.11.006, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1668009600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
幼龄动物毒理学试验的案例分析及考虑要点
单晓蕾 , 黄芳华 * , 姜凯迪
中国医药工业杂志 | 本期主题:儿童药创新研发与科学监管 2022,53(11): 1565-1570
收起
收藏切换
中国医药工业杂志 |本期主题:儿童药创新研发与科学监管 2022 , 53 (11) : 1565 -1570
幼龄动物毒理学试验的案例分析及考虑要点
全屏
[Author(id=1327672071976498032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672072106521458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672071976498032, language=EN, stringName=Xiaolei SHAN, firstName=Xiaolei, middleName=null, lastName=SHAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672072186213235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672071976498032, language=CN, stringName=单晓蕾, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

单晓蕾(1983—),女,硕士,副主任药师,从事新药药理毒理审评工作。

"}, bioImg=null, bioContent=

单晓蕾(1983—),女,硕士,副主任药师,从事新药药理毒理审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672071829697388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, xref=null, ext=[AuthorCompanyExt(id=1327672071854863213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672071867446126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672072249127797, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=huangfh@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672072316236663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072249127797, language=EN, stringName=Fanghua HUANG, firstName=Fanghua, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672072383345528, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072249127797, language=CN, stringName=黄芳华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672071829697388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, xref=null, ext=[AuthorCompanyExt(id=1327672071854863213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672071867446126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672072463037306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672072559506300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072463037306, language=EN, stringName=Kaidi JIANG, firstName=Kaidi, middleName=null, lastName=JIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672072635003773, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, authorId=1327672072463037306, language=CN, stringName=姜凯迪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672071829697388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, xref=null, ext=[AuthorCompanyExt(id=1327672071854863213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672071867446126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671906280518223, companyId=1327672071829697388, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])]
单晓蕾, 黄芳华* , 姜凯迪
作者信息
  • 国家药品监督管理局药品审评中心,北京 100022
通讯作者:
黄芳华(1976—),女,博士,主任药师,从事新药药理毒理审评工作。E-mail:
作者简介:

单晓蕾(1983—),女,硕士,副主任药师,从事新药药理毒理审评工作。

Cases Analysis and Considerations on Juvenile Toxicology Studies
Xiaolei SHAN, Fanghua HUANG* , Kaidi JIANG
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
出版时间: 2022-11-10 doi: 10.16522/j.cnki.cjph.2022.11.006
文章导航
收藏切换

近年来儿童用药成为药物开发热点,儿童人群临床试验逐渐增多。当支持开展儿童临床试验安全性的非临床和临床数据缺乏时,需要考虑开展幼龄动物试验,旨在阐述在其他非临床试验或儿童临床试验中无法得到充分阐述的安全性问题,包括潜在的长期安全性的影响。该文基于2020年发布的ICH S11支持儿童用药开发的非临床安全性指导原则并结合实际案例,阐述了幼龄动物试验的设计和实施的考虑要点,以期为我国儿童用药开发提供参考。

ICH S11  /  幼龄动物试验  /  儿童用药开发

In recent years, paediatric pharmaceutical has become a hotspot of drug development and clinical trials in paediatric population have gradually increased. The conduct of juvenile animal studies(JAS) should be considered only when previous nonclinical and clinical data are insufficient to support paediatric clinical trials. A JAS is designed to address safety concerns that cannot be adequately addressed in other nonclinical studies or paediatric clinical trials, including potential long-term safety effects. The ICH S11 Nonclinical safety testing in support of development of pediatric pharmaceuticals was issued in 2020. This article discusses considerations of JAS, combining with ICH S11 guidance and cases analysis, aiming to provide information for pediatric pharmaceutical development in China.

ICH S11  /  juvenile animal study  /  paediatric drug development
单晓蕾, 黄芳华, 姜凯迪. 幼龄动物毒理学试验的案例分析及考虑要点. 中国医药工业杂志, 2022 , 53 (11) : 1565 -1570 . DOI: 10.16522/j.cnki.cjph.2022.11.006
Xiaolei SHAN, Fanghua HUANG, Kaidi JIANG. Cases Analysis and Considerations on Juvenile Toxicology Studies[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (11) : 1565 -1570 . DOI: 10.16522/j.cnki.cjph.2022.11.006

参考文献 引证文献
排序方式:
[1]
ICH.S11, Nonclinical safety testing in support of development of paediatric medicines [S/OL].[2022-08-04].https://database.ich.org/sites/default/files/S11_Step4_FinalGuideline_2020_0310.pdf.
[2]
FDA.Guidance for industry: nonclinical safety evaluation of pediatric drug products [EB/OL].[2022-08-04].https://www.fda.gov/media/119658/download.
[3]
EMA.Guideline on the need for nonclinical testing in juvenile animals on human pharmaceuticals for pediatric indications [EB/OL].[2022-08-04].https://www.ema.europa.eu/documents/scientific-guideline/guideline-need-non-clinical-testing-juvenile-animals-pharmaceuticals-paediatric-indications_en.pdf.
[4]
JP MHLW.Guideline on nonclinical safety studies in juvenile animals for pediatric drug development [EB/OL].[2022-08-04].https://www.pref.kagawa.lg.jp/documents/7476/161_241015.pdf.
[5]
ICH.M3, Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals [S/OL].[2022-08-04].https://database.ich.org/sites/default/files/M3_R2__Guideline.pdf.
[6]
FDA.Label: vimpat [EB/OB].(2008-10-08)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022253lbl.pdf.
[7]
FDA.NDA 022253 approval letter [EB/OB].(2008-10-28)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022253s000,%20022254s000ltr.pdf.
[9]
FDA.NDA 022253 pharmacology review [EB/OB].(2007-09-28)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022253s000_022254s000TOC.cfm.
[10]
FDA.Label: spinraza [EB/OB].(2016)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209531lbl.pdf.
[11]
FDA.NDA 209531 pharmacology review [EB/OB].(2016-9-23)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/209531Orig1s000TOC.cfm.
[12]
FDA.NDA 209531 approval letter [EB/OB].(2016-12-23)[2022-08-04].https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/209531Orig1s000ltr.pdf.
[13]
BAILEY G P, MARIËN D.The value of juvenile animal studies “What have we learned from preclinical juvenile toxicity studies? Ⅱ” [J].Birth Defects Res B Dev Reprod Toxicol, 2011, 92(4): 273-291.
[14]
VAN DER LAAN J W, VAN MALDEREN K, DE JAGER N, et al.Evaluation of juvenile animal studies for pediatric CNS-targeted compounds: a regulatory perspective [J].Int J Toxicol, 2019, 38(6): 456-475.
[15]
POSOBIEC L M, LAFFAN S B.Dose range finding approach for rodent preweaning juvenile animal studies[J].Birth Defects Res, 2021, 113(5): 409-426.
[16]
FISHER J E Jr, RAVINDRAN A, ELAYAN I.CDER experience with juvenile animal studies for CNS drugs [J].Int J Toxicol, 2019, 38(2): 88-95.
2022年第53卷第11期
81
14
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.11.006
  • 接收时间:2022-10-20
  • 首发时间:2026-11-12
  • 出版时间:2022-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-10-20
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100022

通讯作者:

黄芳华(1976—),女,博士,主任药师,从事新药药理毒理审评工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.11.006
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏